When Prescribing Cures For 'Overpriced' Drugs, Government's First Duty Is Do No Harm

United States News News

When Prescribing Cures For 'Overpriced' Drugs, Government's First Duty Is Do No Harm
United States Latest News,United States Headlines
  • 📰 Forbes
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 53%

When prescribing cures for 'overpriced' drugs, the government's 1st duty is to do no harm

, CMS lacks statutory authority to impose such disclosure, and the speech mandate would violate the First Amendment. If the regulation successfully chills drug advertising, moreover, consumers will be less informed about medical conditions and treatments, which could lead to increases in healthcare costs.

CMMI draws its authority to devise new Medicare drug-reimbursement models from § 1115A of the Social Security Act. The law requires that models be developed in two phases. First-phase tests must be supported by evidence that a defined population is experiencing deficits in care. During first-phase limited testing, CMS can waive the Medicare statutes.

Last, and by no means least, the IPI Model's use of foreign nations' drug prices essentially endorses those nations' extreme price controls, compulsory licensing, and international reference pricing. U.S. government officials have long argued that such policies violate international trade law and chill American pharmaceutical innovation. Through the IPI Model, CMS wants to import the very same policies into U.S. law.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Wall Street's valuation guru: From Uber to Pinterest, all the major IPOs this year are overpricedWall Street's valuation guru: From Uber to Pinterest, all the major IPOs this year are overpricedThis year's hot IPOs have one thing in common — they are all overpriced, according to NYU Stern professor Aswath Damodaran.
Read more »

First major drug distribution company, former CEO, criminally charged in opioid crisisFirst major drug distribution company, former CEO, criminally charged in opioid crisisLaurence Doud III, the former CEO of Rochester Drug Co-Operative, was indicted Tuesday for narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration.
Read more »

U.S. brings first criminal case against major drug distributor over opioidsU.S. brings first criminal case against major drug distributor over opioidsThe U.S. government on Tuesday filed its first criminal charges against a major ...
Read more »

Former CEO of major drug company first to face charges in opioid crisisFormer CEO of major drug company first to face charges in opioid crisisLaurence Doud III, the former CEO of Rochester Drug Co-Operative, was indicted Tuesday for narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration.
Read more »

Pharma distributor Rochester Drug agrees to pay $20 million in first criminal opioid casePharma distributor Rochester Drug agrees to pay $20 million in first criminal opioid caseThe indictment marked the first ever federal criminal charges against company executives for conspiring to illegally distribute opioids.
Read more »



Render Time: 2025-03-13 18:37:39